It has been shown that overexpression of p52 induces castration-resistant growth in human prostate carcinoma LNCaP cell xenografts by inhibiting both cell cycle arrest and apoptotic cell death induced by androgen deprivation [17]. This evidence concerns the gene NFKB2 and prostate carcinoma.